All Pharma News
Invivyd Projects $20-25M Higher 2024 Year-End Cash

Invivyd Projects $20-25M Higher 2024 Year-End Cash
GLOBENEWSWIRE
30 Apr 2024
Share Share
Invivyd Gets HCPCS Codes For PEMGARDA™ From CMS

Invivyd Gets HCPCS Codes For PEMGARDA™ From CMS
GLOBENEWSWIRE
15 Apr 2024
Share Share
Invivyd Announces CEO Transition

Invivyd Announces CEO Transition
GLOBENEWSWIRE
12 Apr 2024
Share Share
Invivyd Provides PEMGARDA Launch Update

Invivyd Provides PEMGARDA Launch Update
GLOBENEWSWIRE
04 Apr 2024
Share Share
Invivyd Reports Full Year 2023 Financial Results and Recent Business Highlights

Invivyd Reports Full Year 2023 Financial Results and Recent Business Highlights
GLOBENEWSWIRE
28 Mar 2024
Share Share
Invivyd`s COVID prophylactic scores FDA emergency nod

Invivyd`s COVID prophylactic scores FDA emergency nod
FIERCE PHARMA
25 Mar 2024
Share Share
Invivyd Announces FDA Authorization for Emergency Use PEMGARDA (Formerly VYD222

Invivyd Announces FDA Authorization for Emergency Use PEMGARDA (Formerly VYD222
GLOBENEWSWIRE
22 Mar 2024
Share Share
Invivyd Announces Interim Exploratory Data on VYD222 from Ongoing CANOPY Trial

Invivyd Announces Interim Exploratory Data on VYD222 from Ongoing CANOPY Trial
GLOBENEWSWIRE
22 Mar 2024
Share Share
Invivyd to Participate at the Guggenheim Healthcare Talks 6th Annual Conference

Invivyd to Participate at the Guggenheim Healthcare Talks 6th Annual Conference
GLOBENEWSWIRE
05 Feb 2024
Share Share
Invivyd Submits Request for EUA to U.S. FDA for VYD222

Invivyd Submits Request for EUA to U.S. FDA for VYD222
GLOBENEWSWIRE
03 Jan 2024
Share Share